Reiter S R, Pollack M H, Rosenbaum J F, Cohen L S
Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
J Clin Psychiatry. 1990 Nov;51(11):470-2.
Nine of 11 patients with social phobia of both the generalized and performance type responded to treatment with clonazepam in total daily doses ranging from 0.75 to 3 mg. Only 2 of these 9 had comorbid panic disorder; the benefit for social phobic symptoms appears independent of clonazepam's putative efficacy for panic disorder.
11名患有广泛性社交恐惧症和表演型社交恐惧症的患者中，有9名对氯硝西泮治疗有反应，每日总剂量为0.75至3毫克。这9名患者中只有2名患有共病惊恐障碍；氯硝西泮对社交恐惧症症状的疗效似乎独立于其对惊恐障碍的假定疗效。
